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Abstract
Background—Pneumonia, a known complication of coronary artery bypass (CABG) surgery,
significantly increases a patient’s risk of morbidity and mortality. While not well characterized,
red blood cell transfusions (RBC) may increase a patient’s risk of pneumonia. We describe the
relationship between RBC transfusion and post-operative pneumonia after CABG surgery.
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Methods—A total of 16,182 consecutive patients underwent isolated CABG surgery between
2011 and 2013 at one of 33 hospitals in the state of Michigan. We used multivariable logistic
regression to estimate the odds of pneumonia associated with the use or number (0, 1, 2, 3, 4, 5,
>6) of RBC units. We adjusted for predicted risk of mortality, pre-operative hematocrit, history of
pneumonia, cardiopulmonary bypass duration and medical center. We confirmed the strength and
direction of these relationships among selected clinical subgroups in a secondary analysis.
Results—576 (3.6%) patients developed pneumonia and 6,451 (39.9%) received RBC
transfusions. There was a significant association between any RBC transfusion and pneumonia
(ORadj 3.4, p<0.001). There was a dose-response between number of units and odds of
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pneumonia, ptrend<0.001. Patients receiving only 2 units of RBCs had twofold (ORadj 2.1,
p<0.001) increased odds of pneumonia. These findings were consistent across clinical subgroups.
Conclusions—We found a significant, volume-dependent association between an increasing
number of RBCs and odds of pneumonia, which persisted after adjusting for pre-operative patient
characteristics. Clinical teams should explore opportunities for preventing a patient’s risk of RBC
transfusions, including reducing hemodilution or adopting a lower transfusion threshold in a stable
patient.
Keywords
blood management; conservation; consequences; infection; coronary artery bypass grafts; CABG;
complications
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INTRODUCTION
Nearly half of patients undergoing coronary artery bypass grafting (CABG) surgery are
exposed to red blood cell (RBC) products. While large volumes (3+ units) of transfusions
are typically given to preserve life in cases of acute blood loss, smaller quantities may be
potentially avoidable. Indeed, research suggests that patients exposed to 1–2 units of RBCs
may have a 16% increase in risk adjusted mortality.1
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For every 20 patients who undergo cardiac surgery, one will develop a major infection, with
pneumonia being the most common.2 Such rates of pneumonia and other healthcareassociated infections after CABG surgery have been shown to vary considerably across
medical centers – a finding not accounted for by differences in patient case mix.3 Prior
studies have suggested that exposure to allogeneic blood may explain some of this variance.4
Findings from a recent multi-center study suggested a 23% increased hazard of infection
within 65 days of cardiac surgery associated with every 1 unit increase in RBC
transfusions.2 The strength of this relationship was most evident for pneumonia and
bloodstream infection. While large, this study included a heterogeneous population (i.e. a
mix of cardiac surgical procedures) observed through year 2010. Given that this was a
volunteer population and the response rate was not available, we intended to explore this
hypothesis in more depth, capturing a contemporaneous series of consecutive patients
undergoing CABG surgery over a 3-year time period.
We leveraged a prospective, contemporaneous multi-institutional cohort study to
characterize the relationship between the use and number of RBC transfusions and postoperative pneumonia after isolated CABG surgery.
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METHODS
This study was approved by the Institutional Review Board (IRB) of the University of
Michigan Health System for the Michigan Society of Thoracic and Cardiovascular Surgeons
Quality Collaborative.
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The Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative
(MSTCVS-QC) is a surgeon-led, voluntary, multidisciplinary group consisting of all 33
hospitals that perform cardiac surgical procedures on adults in the state of Michigan.5 All
programs use the Society of Thoracic Surgeons (STS) data collection form and submit data
on a quarterly basis to both the STS database and the MSTCVS-QC data warehouse, which
specifically includes other cardiac surgical data including perfusion, readmission and
specific mortality data. Participating sites are routinely audited for data validity and accuracy
as part of the MSTCVS-QC audit system, with sites on average demonstrating excellent
overall scores (>98% data accuracy).
We included 16,182 patients undergoing isolated CABG surgery at any of 33 medical
centers in Michigan between 2011 and 2013.
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Measures
The utilization of non-autologous RBC transfusions (intra- or post-operatively) were
determined.
The primary outcome for this analysis was post-operative pneumonia according to STS
criteria. Pneumonia is captured in the STS database when a physician or physician extender
has documented the diagnosis in the medical record based on symptoms (positive sputum
cultures, trans tracheal fluid, bronchial washings) and radiologic evidence (e.g. chest
radiograph diagnostic of pulmonary infiltrates).
Statistical Analysis
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Standard statistical tests were used, including chi-square tests for categorical data, and twosided Wilcoxon rank-sum tests for non-normally distributed continuous variables. Trends in
patient characteristics, processes of care, and clinical outcomes were tested using the Cuzick
non-parametric test of trend.6
Relative risks and odds ratios were computed for univariate comparisons of patient and
disease characteristics against RBC transfusion use and post-operative pneumonia
occurrence, respectively.

Author Manuscript

A multivariable logistic regression model was used to estimate the effect of the use and
volume of RBC transfusions on post-operative pneumonia. For this analysis, we modeled
each patient’s exposure to RBC transfusions as: no transfusion, 1 unit, 2 units, 3 units, 4
units, 5 units, or ≥ 6 units. In this model, covariates based on clinical relevance included the
patient’s pre-operative risk of mortality (Society of Thoracic Surgeon’s PROM), preoperative Hct, pre-operative pneumonia, and medical center. Dummy variables were used to
account for medical center.
In sensitivity analysis, we explored the effect of transfusions and pneumonia among distinct
clinical subgroups: age (<60, 60–69, ≥70), sex, acuity (elective, urgent, emergent), chronic
obstructive pulmonary disease, smoking (no history, smoking within 1 year, smoking within
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2 weeks), and use of any other blood products (fresh frozen plasma, platelets,
cryoprecipitate, and factor VIIa).
Statistical analyses were performed using Stata 13.0 (College Station, TX). The two-tailed
tests were considered significant at p<0.05.

RESULTS

Author Manuscript

Of the 16,182 patients, the age ranged from 25–95 years, 26.6% were female, 13.6% had a
body mass index ≥ 37kg/m2, 18.9% had smoked within 2 weeks of surgery, 2.7% had a
recent history of pneumonia, 12.6% had moderate-severe chronic lung disease, 44.8% had
diabetes, 12.7% congestive heart failure, 16.9% peripheral arterial disease, 25.5% had preoperative hematocrit<36%, 3.0% had a previous cardiac surgical operation, 14.8% had an
ejection fraction<40%, 60.9% were urgent, 96.5% had the appropriate type and 99.2% the
appropriate timing of pre-operative antibiotics.
Red blood cells were transfused among 39.9% of patients: 1 unit (9.1%), 2 units (13.4%), 3
units (5.7%), 4 units (4.5%), 5 units (2.5%), and ≥6 units (5.1%), Figure 1. 8.3% of patients
received transfusions intra-operatively, 20.7% post-operatively, and 10.9% intra- and
postoperatively. Post-operative pneumonia developed among 3.6% of patients. Patients
receiving small quantities of RBCs (i.e. 1 or 2 units) were transfused more often only in the
post-operative setting, p<0.001. (Figure 2) Patients exposed to larger quantities of RBCs
were more likely to receive transfusions in the intra- and post-operative settings.
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Patients transfused with RBCs were more likely to be older, female, have greater body mass
index, have a history of pneumonia, moderate-severe chronic lung disease, diabetes,
congestive heart failure, peripheral arterial disease, lower pre-operative hematocrit, have had
a previous operation, lower ejection fraction, and greater acuity. (Table 1) They were less
likely to have smoked within two weeks of surgery and appropriate selection of antibiotics.
Patients developing pneumonia were more likely to be older, and have greater body mass
index, have a history of smoking, pneumonia, moderate-severe chronic lung disease,
diabetes, congestive heart failure, peripheral arterial disease, lower pre-operative hematocrit,
lower ejection fraction, and greater acuity. (Table 1)
Patients exposed to RBC transfusions had a significant 3.4-fold increased odds of
pneumonia (ORadj 3.4, p<0.001). The odds of pneumonia increased with the transfusion of
more RBC units, ptrend<0.001, Table 2. These finding were quantitatively and qualitatively
similar when explored in our sensitivity analyses, Table 3.
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DISCUSSION
In Michigan, pneumonia occurs after CABG surgery in 1 of every 28 patients, although is 1
of every 8 patients among those receiving perioperative RBC transfusions. These findings
are important for at least two reasons. First, our study reflects the experience of the entire
isolated CABG surgical population in the state of Michigan (exclusive of patients receiving
cardiac surgical care at federal facilities). Thus, unlike trials, our study does not suffer from
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selection bias.7 Second, we report a dose-response relationship between RBC transfusions
and incidence of post-operative pneumonia. Importantly, patients receiving only 2 units of
RBCs had a twofold increased odd of pneumonia, even after adjusting for baseline risk,
duration of the cardiopulmonary bypass period and medical center. These findings suggest a
potential strategy for reducing a patients’ risk of pneumonia, namely through blood
conservation.
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Prior studies in and outside of cardiac surgery have shed light on the relationship between
RBC transfusions and infections.8–10 Taylor and colleagues undertook a study of adult
patients admitted to a single institution between 2001–2003.8 Nosocomial infection and
other adverse outcomes were prospectively tracked, and rates compared by use of RBC
transfusions. Patients receiving transfusions had higher rates of infections (14.3% vs. 5.8%,
p<0.001), including pneumonia (7.2% vs. 3.4%). This finding was consistent across strata of
increasing pre-operative risk, p<0.001. Interestingly, the number of RBC units was an
independent risk factor for infections, p=0.005. Murphy and colleagues used a single-center
institutional database to assess the impact of RBC transfusions on clinical outcomes and
costs among adult cardiac surgical patients.9 Nadir hematocrit occurring during the first 12
hours post-operatively was collected, as was the number of RBC units transfused. A
propensity score was derived to estimate the probability for a transfusion, and then
subsequently used to estimate the risk of any of 2 composite endpoints: infection
(respiratory infection, wound infection or septicemia) or ischemia (myocardial infarction,
stroke, renal). The authors found that the use of a RBC transfusion was associated with a
3.7-fold increased odds of infection, and 4.1-fold increased odds of ischemic injury. In both
cases, they also found a dose-dependent relationship with the number of RBC units
transfused.
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Prior studies have documented immunomodulation secondary to leukocytes within
allogeneic blood products.11 While still not clearly understood, transfusion-associated
immunomodulation (TRIM) may occur secondary to the accumulation of white blood cells
and plasma (among others) in stored RBC units. It is thought that allogeneic white blood
cells may cause immunosuppression among recipients of RBC transfusions. TRIM has been
associated with bacterial infection, multi-organ injury and mortality.12 Leukoreduction of
these stored units have been consistently associated with low rates of non-hemolytic febrile
transfusion reactions.13–15 Hebert and colleagues evaluated the impact of leukoreduction
across 23 Canadian hospitals subsequent to a universal prestorage leukoreduction
program.16 Outcomes evaluated included mortality, infections, fever and antibiotic use
among 14,786 patients (6,982 during a period prior to the implementation, and 7,804 after
the program’s implementation) who received RBC transfusions secondary to cardiac
surgery, repair from hip fracture, or during their intensive care unit stay following a surgical
intervention or trauma. Adjusted in-hospital mortality rates were lower (ORadj 0.87) after
leukoreduction (7.03% vs. 6.19%, p=0.04). The direction and magnitude were similar, albeit
not significant, among cardiac surgical patients (OR 0.88, p=0.20). There was a small, yet
protective, effect for suspected (ORadj 0.94, p=0.21) and confirmed infection (ORadj 0.97,
p=0.63) secondary to the leukoreduction program. The program was also associated with a
significantly lower risk of fever (ORadj 0.86, p<0.001) and antibiotic usage (ORadj 0.90,
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p=0.03). We were unable to assess the rate, and therefore impact, of RBC leukoreduction on
risk of post-operative pneumonia.
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We recognize some limitations to our present study. First, we recognize that similar to other
observational studies, we cannot rule out the effect of unmeasured confounding. We
employed standard statistical approaches, including multivariable regression to adjust for
differences in pre-operative characteristics, cardiopulmonary bypass duration and institution.
Second, while we do not have information concerning the indication for the RBC
transfusion, we adjusted for the patient’s pre-operative Hct as a proxy of the patient’s
oxygen carrying capacity at the time of the operation. Transfusion of large quantities of
RBCs is likely for volume replacement secondary to active bleeding. Nonetheless, patients
receiving small quantities of RBCs (e.g. 2 units), which may be more discretionary in nature,
had a 2-fold increased odds of post-operative pneumonia. Third, we did not collect
information concerning the use of prestorage leukoreduction of RBC transfusions nor the
length of storage.
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Given the implications associated with increased exposure to transfusions, our findings
suggest that clinical teams should consider opportunities for minimizing a patient’s exposure
to RBC units, principally through increasing a patient’s oxygen carrying capacity. In a recent
meta-analysis, Rohde found no statistically significant difference in risk of infection
associated with a restrictive transfusion strategy [restrictive vs. liberal, RR 1.30 (CI95%
0.85, 1.97)].17 Nonetheless, other strategies may exist to reduce the delivery of RBC
transfusions. Clinical teams may consider discharging stable inpatients to increase their preoperative hemoglobin level. In the most recent version of its blood management guidelines,
the Society of Thoracic Surgeons found Class IIa, Level B evidence to support the use of
pre-operative erythropoietin (EPO) plus iron several days prior to surgery among patients
presenting with anemia or those at high risk for post-operative anemia.18 Authors of this
guideline recommendation recognized the need for clinical teams to weigh the benefit
associated with EPO against the risk of thromboembolic events and hypertension, as well as
the cost associated with its use.
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Other strategies found to be reasonable in lowering RBC transfusions include the use of:
mini circuits to reduce prime volume (Class I, level A), modified ultrafiltration (Class I,
level A), antifibrinolytics (Class IIa, level B), centrifugation of salvaged blood (Class IIa,
Level A), and multidisciplinary blood management teams (Class IIa, Level B). Databases
such as the PERForm registry (http://www.performregistry.org/) are well equipped to assist
clinical teams in tracking and evaluating the use of these and other strategies. Clinical teams
should consider employing these practices as part of a broader blood management program
and assess their association with the risk of post-operative pneumonia and other sequelae.
In this large, statewide, observational study, we found a significant, volume-dependent
association between an increasing number of RBCs and subsequent onset of pneumonia,
even after adjustment. Our findings suggest that reduction of transfusions (through blood
conservation strategies, including reducing hemodilution or adopting a lower transfusion
threshold in a stable patient) may provide an opportunity for reducing the risk of postoperative pneumonia.
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Figure 1.

Rate of Pneumonia by Number of RBC Units After Isol CABG Surgery
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Figure 2.

Distribution of Transfusions by Timing and Post-operative Pneumonia
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Periperhal Arterial Disease

Transfusion

Author Manuscript

No Transfusion

99.1

95.8

9.6

64.9

25.5

27.9

26.8

19.5

25.8

3.3

18.2

19.4

25.5

36.8

29.2

Pneumonia

0.86

0.81

4.15

1.51

Ref

Ref

1.01

1.53

2.28

1.11

Ref

1.01

1.14

1.84

2.10

OR

(0.35,2.12)

(0.53,1.23)

(3.01,5.74)

(1.24,1.83)

(0.80,1.26)

(1.20,1.96)

(1.81,2.88)

(0.70,1.77)

(0.77,1.33)

(0.88,1.47)

(1.45,2.33)

(1.74,2.52)

CI 95%

Author Manuscript

Variable

<0.001

<0.001

<0.001

ptrend
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Author Manuscript

Author Manuscript

Author Manuscript
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3.5
4.4
6.6
14.3

3

4

5

6+

1.5
2.0
3.7
5.1
7.9
14.3

1

2

3

4

5

6+

1.0

Hct, last preop

1.4

Remote
1.00

1.7

Recent

Cardiopulmonary Bypass Duration (min)

Ref

No Hx

Pneumonia, %

27.5

Predicted Risk of Mortality

ptrend

Ref

None

Number of RBC Transfusions

(1.0, 1.0)

(1.0, 2.1)

(1.1, 2.7)

(1.0, 1.1)

(5.6, 136.7)

(10.6, 19.2)

(5.2, 12.1)

(3.5, 7.3)

(2.6, 5.3)

(1.5, 2.8)

(1.0, 2.1)

(11.4, 17.9)

(4.5, 9.6)

(3.2, 6.0)

(2.5, 4.8)

(1.4, 2.5)

(0.93, 2.0)

(3.2, 4.6)

CI95%

0.51

0.09

0.02

<0.001

<0.001

<0.001

<0.001

<0.001

<0.001

<0.001

<0.001

0.06

<0.001

<0.005

<0.004

<0.003

<0.002

<0.001

0.12

<0.001

p-value

Adjusted for: STS predicted risk of mortality, pre-operative Hct, pre-operative pneumonia, perfusion time, medical center Hospital-level estimates are not included ROC for adjusted model: 0.81

a

1.9

2

Adjusteda

1.4

ptrend

Ref

1

3.8

OR

None

Number of RBC Transfusions

Any Transfusion

Crude

Variable

Crude and adjusted odds of post-operative pneumonia by use and volume of red blood cell transfusions

Author Manuscript
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0.8
2.1

60–69

>=70

1.0

Females

NA

1.1
1.7

Smoking within 1 Year

Smoking within 2 Wks
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0.3

Yes

1.4

1.9

2.3

0.9

2.3

3.1

3.8

3.1

4.1

2.1

2.3

4.4

5.1

1.8

6.6

2.7

3.9

12.8

2.7

4.3

2.1

4.6

4.7

4.8

2.4

3

3.4

7.1

5.1

6.1

10.1

7.3

4.6

8.1

4.7

4.3

2.3

7.7

5.7

5.5

5.8

4

3.9

22.1

15.7

11.5

16.1

6.0

8.3

10.9

7.3

5.7

3.6

11.0

10.4

7.2

6.8

5

1.3 (1.2, 1.5)

1.6 (1.5, 1.7)

1.5 (1.4, 1.7)

1.5 (1.3, 1.7)

1.6 (1.5, 1.7)

17.1

13.4

14.9

13.9

14.9

11.0

15.6

18.5

18.6

8.8

≥6

1.6 (1.4, 1.8)

1.6 (1.5, 1.6)

1.6 (1.3, 1.9)

1.6 (1.5, 1.6)

1.6 (1.4, 1.7)

1.5 (1.4, 1.7)

1.6 (1.5, 1.7)

1.6 (1.5, 1.7)

1.6 (1.5, 1.8)

1.5 (1.3, 1.6)

Trenda (CI95%)

Odds ratio reflecting the relative odds of pneumonia per 1 unit increase in red blood cells

a

Adjusted for: predicted risk of mortality, pre-operative Hct, pre-operative pneumonia, perfusion time, medical center

1.6

No

Other Blood Products

1.5

No Smoking Hx

2.3

2.1

Yes

Smoking

1.3

No

Chronic Obstructive Pulmonary Disease
2.0

2.3

1.6

Emergent/Salvage

2.0

1.3

Urgent

1.9

1.0

2.7

2.5

2.7

1.1

2

Elective

Acuity

1.7

Males

Sex

1.5

1

Number of Perioperative Transfusion Units

<60

Age

No units (Reference)

Author Manuscript

Adjusted odds ratios of pneumonia for increasing units of transfusions

Author Manuscript
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